Editorial Board

Dr. Mohd Zulkiflee bin Abu Bakar

Dr. Mohd Zulkiflee bin Abu Bakar
Associate Professor
Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine,
University of Malaya

Biography :

KNOWLEDGE AND AWARENESS ABOUT PROSTATISM AMONG MALE PATIENTS WHO COME TO KLINIK KESIHATAN BUKIT KUDA, KLANG, 2009/2010, 60092  Marzuki, Pilot Study on the Prevalence of Otitis Media with Effusion in Children undergoing Cleft Palate Repair, 2011/2012, 90039  Shantini Jaganathan, Isolation of HDM from nasal vestibule and cavity  Mohd Hafiz Mahboob, "Audiological Outcome of Cochlear Implant in UMMC", 2011/2012  Numerous numbers of Masters Students

Research Interest :

A study on prevalence of posterior choanal stenosis in post irradiated NPC patient and to identify any predisposing factors, Principal Investigator (PI), 2009-2010, Geran Penyelidikan Universiti Malaya (UMRG), National  Chronic Rhinosinusitis and Nasal Polyposis Cohort Study, RM61,000, Co-Investigator, 2008-2012, Geran Penyelidikan Universiti Malaya (UMRG), National  Clinical applications of Medial Olivocochlear Bundle in Human (Neurophysiology), Co-Investigator, 2008-2012  Deep Neck Infection: Epidemiology and Clinical Status -A Local Spectrum, Student, 2004-2008, University of Malaya, University  Epithelial Migration of The Atelectatic Pars Flacida Tympanic Membrane, RM21,500, Principal Investigator (PI), 2012-2014, Short Term Research Fund (Vote F)(PJP), National  A Phase III, Open-label, Randomized, Multi-center Study of the Effects of Leukocyte Interleukin, Injection [Multikine*] Plus Standard of Care (Surgery + Radiotherapy or Surgery + Concurrent Chemo radiotherapy) in Subjects with Advanced Primary Squamous Cell Carcinoma of the Oral Cavity / Soft Palate Versus Standard of Care Only  A Phase III Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK3475-048)  A phase II, multi-centre, single arm, global study of MEDI4736 Monotherapy in patient with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) - (HAWK)  A phase II, randomized, open-Label, multi-center, global study of MEDI4736 monotherapy, tremelimumab monotherapy, and MEDI4736 in combination with tremelimumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) - (CONDOR)  DEVELOPING A GENRE AND LINGUISTIC FRAMEWORK FOR THE TEACHING AND ASSESSMENT OF MEDICAL STUDENTS’ CASE PRESENTATIONS (UPM-UM)  Study on Epigenetic Changes in Nasopharyngeal Cancer (20159-1642)